Price of medicines in a small market country: a comparative approach

Abstract Objectives Affordability and availability of medicinal products depend on governmental policies, healthcare budgets pricing. Pharmaceutical price regulation can improve the accessibility affordability essential products. In Europe, product prices are assigned individually by each country. The study aimed to compare indicated for cardiovascular (n = 18) respiratory disease 9) available retail in community pharmacies five European countries. Methods Unit dose North Macedonia, Malta, Slovenia, Greece UK were compared. Key findings Malta had highest unit majority 11) used 8) disease. Conclusion Variation commonly dispensed exists. Having a more thorough knowledge about medicines different countries contribute making policies that will ultimately make affordable accessible patients.